Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Smith, Susan C."'
Autor:
Thompson, Philip A. *, Tam, Constantine S. *, O'Brien, Susan M., Wierda, William G., Stingo, Francesco, Plunkett, William, Smith, Susan C., Kantarjian, Hagop M., Freireich, Emil J., Keating, Michael J. *
Publikováno v:
In Blood 21 January 2016 127(3):303-309
Autor:
Falchi, Lorenzo, Keating, Michael J., Marom, Edith M., Truong, Mylene T., Schlette, Ellen J., Sargent, Rachel L., Trinh, Long, Wang, Xuemei, Smith, Susan C., Jain, Nitin, Estrov, Zeev, O'Brien, Susan, Wierda, William G., Lerner, Susan, Ferrajoli, Alessandra
Publikováno v:
In Blood 1 May 2014 123(18):2783-2790
Publikováno v:
Journal of Allied Health, 2012 Apr 01. 41(1), e21-e25.
Externí odkaz:
https://www.jstor.org/stable/48721720
Autor:
Smith, Susan C., Penumetcha, Meera
Publikováno v:
Journal of Allied Health, 2010 Jul 01. 39(2), e69-e75.
Externí odkaz:
https://www.jstor.org/stable/48721619
Autor:
Rousseau, Raphaël F. *, Haight, Ann E., Hirschmann-Jax, Charlotte, Yvon, Eric S., Rill, Donna R., Mei, Zhuyong, Smith, Susan C., Inman, Shannon, Cooper, Kristine, Alcoser, Pat, Grilley, Bambi, Gee, Adrian, Popek, Edwina, Davidoff, Andrew, Bowman, Laura C., Brenner, Malcolm K., Strother, Douglas
Publikováno v:
In Blood 1 March 2003 101(5):1718-1726
Autor:
Smith, Susan C.1 susanc@uab.edu, O’Hagan, Emma C.2 emma.ohagan@med.wmich.edu
Publikováno v:
Journal of the Medical Library Association. Jul2014, Vol. 102 Issue 3, p196-200. 5p.
Autor:
Thompson, Philip A, O'Brien, Susan M, Wierda, William G, Ferrajoli, Alessandra, Stingo, Francesco, Smith, Susan C, Burger, Jan A, Estrov, Zeev, Jain, Nitin, Kantarjian, Hagop M, Keating, Michael J
Publikováno v:
Cancer, vol 121, iss 20
BackgroundIbrutinib is active in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). In patients treated with ibrutinib for R/R CLL, del(17p), identified by interphase fluorescence in situ hybridization (FISH), is associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::9c3350437fc41e9a7fa636e4882f9138
https://escholarship.org/uc/item/4655m3tz
https://escholarship.org/uc/item/4655m3tz
Autor:
Thompson, Philip A., O’Brien, Susan M., Wierda, William G., Ferrajoli, Alessandra, Stingo, Francesco, Smith, Susan C., Burger, Jan A., Estrov, Zeev, Jain, Nitin, Kantarjian, Hagop M., Keating, Michael J.
Ibrutinib is active in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). In patients treated with ibrutinib for R/R CLL, del(17p), identified by interphase fluorescence in situ hybridization (FISH), is associated with inferi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6b8ac6ebb80b5342aa1cfd55001742b
https://europepmc.org/articles/PMC4866653/
https://europepmc.org/articles/PMC4866653/
Autor:
Walsh, Teri, Smith, Susan C., Matus, Jordan, Van Tine, Julia, Johnson, Joely, O'Donnell, Sara Altshul
Publikováno v:
Prevention. Jun99, Vol. 51 Issue 6, p34. 6p. 7 Color Photographs.